Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services (1)
Select solutions (1)
Active Filters (2)
Clear All
13 - 23 of 23 Results
Sort by:
Best Match

HTRF platform for anticancer drug discovery: from 2D and 3D cell cultures to xenograft models
Learn how to analyze cell signaling pathways on in vitro and in vivo sample types routinely used in the anticancer drug discovery process.

Neurodegeneration and associated diseases
See this infographic for a summary on the key diseases related to neurodegeneration, associated risk factors, and specific cell types involved in degeneration.

Eyes on synaptotagmin 7 (SYT7) in synaptic function and neuroplastic health for cognitive decline
Researcher, Dr. Jason Vevea, describes the role of synaptotogmin 7 in the synaptic vesicle cycle and the experimental steps taken to discover that SYT7 supports asynchronous release, short-term synaptic plasticity, and synaptic vesicle replenishment.

Accelerating immuno-oncology therapeutic development: choosing the best preclinical model
Selecting the appropriate preclinical model for immuno-oncology therapeutic development.

Unlocking insights with AlphaLISA anti-drug antibodies detection assays
Unlock ADA insights with AlphaLISA technology.

Antibody-based therapeutic modalities in oncology
Explore monoclonal antibody-based cancer therapeutics in this white paper, covering mechanism of action, development, and challenges.

High-throughput DNA quantification for next generation sequencing on the VICTOR Nivo
In this application note, we compare the results of two dsDNA quantification methodologies using the VICTOR Nivo plate reader.

Excellent sensitivity from the EnVision Nexus multimode plate reader for AlphaLISA detection
This application note demonstrates the AlphaLISA detection capabilities of the EnVision Nexus and compares it to the EnVision 2105.

Utilizing AlphaLISA technology to screen for inhibitors of the CTLA-4 immune checkpoint
In this Application Note, AlphaLISA® assays are used for screening novel CTLA-4 blocking drugs. Learn more.

Solution for accurate research on fibrosis
Advance your research on fibrosis and benefit from Revvity’s broad offering of reagent technologies.

Understanding the anti-inflammatory effects of a microbiota-derived metabolite using high-content analysis and AlphaLISA
Here we combine HCA and AlphaLISA cytokine detection to further characterize the anti-inflammatory effect of UroA on LPS-stimulated human macrophage-like cells.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.